1 |
|
Recent advances in the synthesis and anticancer activity of some molecules other than nitrogen containing heterocyclic moeities |
Mini Reviews in Medicinal Chemistry |
17 |
17 |
1602-1632 |
2017 |
Bentham Science Publishers |
2 |
|
Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder |
International journal of biological macromolecules |
81 |
|
49-59 |
2015 |
Elsevier |
3 |
|
A review on anticancer potential of bioactive heterocycle quinoline |
European journal of medicinal chemistry |
97 |
|
871-910 |
2015 |
Elsevier Masson |
4 |
|
Design, synthesis, and biological evaluation of novel quinazoline clubbed thiazoline derivatives |
Archiv der Pharmazie |
350 |
2 |
1600298 |
2017 |
|
5 |
|
Design and synthesis of quinazoline-3, 4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor |
Bioorganic chemistry |
71 |
|
181-191 |
2017 |
Academic Press |
6 |
|
Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities |
European journal of medicinal chemistry |
125 |
|
143-189 |
2017 |
Elsevier |
7 |
|
Current perspectives on quinazolines with potent biological activities: A review |
Synthetic Communications |
48 |
10 |
1099-1127 |
2018 |
Taylor & Francis |
8 |
|
Emergence of promising novel DPPâ4 inhibitory heterocycles as antiâdiabetic agents: A review |
Archiv der Pharmazie |
351 |
8 |
1800127 |
2018 |
|
9 |
|
DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective |
European journal of medicinal chemistry |
158 |
|
559-592 |
2018 |
Elsevier Masson |
10 |
|
Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains |
European journal of medicinal chemistry |
171 |
|
310-331 |
2019 |
Elsevier Masson |
11 |
|
Novel 9-(2-(1-arylethylidene) hydrazinyl) acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells |
Bioorganic chemistry |
88 |
|
102962 |
2019 |
Academic Press |
12 |
|
Medicinal prospects of antioxidants: A review |
European journal of medicinal chemistry |
178 |
|
687-704 |
2019 |
Elsevier Masson |
13 |
|
Recent progress of benzimidazole hybrids for anticancer potential |
Current Medicinal Chemistry |
27 |
35 |
5970-6014 |
2020 |
Bentham Science Publishers direct |
14 |
|
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review |
European journal of medicinal chemistry |
184 |
|
111773 |
2019 |
Elsevier Masson |
15 |
|
Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption |
Toxicology Mechanisms and Methods |
30 |
5 |
370-377 |
2020 |
Taylor & Francis |
16 |
|
Design, synthesis, and biological evaluation of imidazopyridineâlinked thiazolidinone as potential anticancer agents |
Archiv der Pharmazie |
353 |
10 |
2000071 |
2020 |
|
17 |
|
Free radical scavengers: An overview on heterocyclic advances and medicinal prospects |
European Journal of Medicinal Chemistry |
204 |
|
112607 |
2020 |
Elsevier Masson |
18 |
|
"Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. |
Bioorganic Chemistry |
78 |
|
|
2018 |
|
19 |
|
Design, in-silico study and biological evaluation of newly synthesized 3-chlorobenzofuran congeners as antitubercular agents |
Arabian Journal of Chemistry |
14 |
4 |
103034 |
2021 |
Elsevier |
20 |
|
current quest in natural bioactive compounds for Alzheimerâs disease: Multi-targeted-designed-ligand based approach with preclinical and clinical based evidence |
Current Drug Targets |
22 |
6 |
685-720 |
2021 |
Bentham Science Publishers |
21 |
|
Comparing the Antidiabetic Effects of Aqueous Extracts of Stevia rebaudiana and Gymnema sylvestre In Normal and Streptozotocin Induced Experimental Rats |
Saudi Journal of Medical and Pharmaceutical Sciences |
7 |
7 |
320-325 |
2021 |
Scholars Middle East Publisher |
22 |
|
Indole derivatives (2010â2020) as versatile tubulin inhibitors: Synthesis and structureâactivity relationships |
Future Medicinal Chemistry |
13 |
20 |
1795-1828 |
2021 |
Taylor & Francis |
23 |
|
Medicinal prospects of antioxidants: a review. |
|
|
|
|
2019 |
|
24 |
|
Synthesis, molecular docking, and pharmacological evaluation of 5-(4-(2-(5-ethyl pyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2, 4-dione against HFD-induced diabesity via interaction with the CB1 receptor |
Iranian Journal of Basic Medical Sciences |
25 |
8 |
1028 |
2022 |
IJBMS |